title: Peritransplant palifermin use and lymphocyte recovery after T-cell replete, matched related allogeneic hematopoietic cell transplantation.
authors.affiliation: The Blood and Marrow Transplantation Program, University of Minnesota, Minneapolis, USA.
authors.forename: Romee
authors.initials: R
authors.lastname: Rizwan
authors.forename: John E
authors.initials: JE
authors.lastname: Levine
authors.forename: Todd
authors.initials: T
authors.lastname: Defor
authors.forename: James L M
authors.initials: JL
authors.lastname: Ferarra
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Weisdorf
authors.forename: Bruce R
authors.initials: BR
authors.lastname: Blazar
authors.forename: Michael R
authors.initials: MR
authors.lastname: Verneris
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D015331:Cohort Studies; D004311:Double-Blind Method; D005260:Female; D051523:Fibroblast Growth Factor 7 / Q000627:therapeutic use*; D006086:Graft vs Host Disease / Q000517:prevention & control; D019337:Hematologic Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013601:T-Lymphocytes / Q000166:cytology / Q000187:drug effects*; D014184:Transplantation, Homologous; D055815:Young Adult
chemical_list: D051523:Fibroblast Growth Factor 7